Reply To Sidney Taurel's Lilly Shareholders' Meeting Statements-Part 1
Mr. Taurel's Statement
With its stock price near a 52-week low, its industry's image tarnished and its top drug losing sales, Eli Lilly and Co. faces a fight to survive in its 130th year, the drug maker's chairman says.
Now perhaps it is a bit more comprehensible what beef and pork insulin users have been shouting into your deaf ears regarding THEIR struggle for survival. We are still here, shouting--have your listening skills improved?
In a report to shareholders Monday, Sidney Taurel sketched a bleak picture of Lilly's workaday world, calling it "by far the toughest I have seen in my almost 35 years in this industry."
Your step-by-step gangster-style "hit list" for all beef and pork insulins, beginning with pure beef Iletin I and ending in July 2005, when the last two "members" of the "family" were "rubbed out", hasn't made life pleasant from this perspective. Tough over here became toughest when you systematically eliminated these insulins--attempting to force more expensive in-patent insulins on everyone--purely in the name of Lilly profit. No assistance to obtain comparable replacement products without need of import were EVER made for US users. In less than 35 years, choice of insulin easily available has dropped dramatically. Only a few years ago, there were 40 products on the market Compare that to current market offerings from all 3 major insulin producers.